Advances in management of melanoma. - Wikidata - thesis-toulmin - TriplyDB

Advances in management of melanoma.

Advances in management of melanoma.

http://www.wikidata.org/entity/Q47590210

about

Advances in management of melanoma.

http://www.wikidata.org/entity/Q47590210

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Advances in management of melanoma.

@en

Advances in management of melanoma.

@nl

type

label

Advances in management of melanoma.

@en

Advances in management of melanoma.

@nl

prefLabel

Advances in management of melanoma.

@en

Advances in management of melanoma.

@nl

P1433

Q47590210-7B3D5134-3E87-406D-A32D-6F18A7A127A9

P1476

Q47590210-116B0615-1C71-4321-922F-7D8F253C5A76

P2093

Q47590210-E622B7D8-DB77-479E-9670-0C822153DFE9

P2860

Q47590210-0777669B-2CC5-45DD-8C8C-9F6F6A885DC9

Q47590210-0F95C405-DE3B-4592-B030-2B46F28E494B

Q47590210-190A129F-0BCA-4D58-A6F3-D10A194FC3E8

Q47590210-23932541-4424-47A1-A023-ED9E3353CF4F

Q47590210-2A4BBCE0-6D66-45E3-86AC-927B3240EFF5

Q47590210-38596076-509E-44EC-8E26-183343E2DF9D

Q47590210-3A46DCAE-6E9B-4F3F-9696-803383B23470

Q47590210-3D396942-E274-4A08-BFC4-2A81658DC6D0

Q47590210-412A6152-26F7-4721-A6AB-B4EFD7BB0EFF

Q47590210-48098C65-9115-43A2-B0C5-FE4EBD595D53

P304

Q47590210-4F96DFE4-F710-497B-A94C-06DC3AE7316B

P31

Q47590210-3EC0D0AF-95CA-48BE-A2C1-0FED1CDFB3C7

P356

Q47590210-3518A84F-3150-403C-8DE2-812FE4077018

P433

Q47590210-8D7DA313-F9F4-4C5B-8F0C-F7F5383F0183

P478

Q47590210-B90B09CE-5116-4289-976D-F39E8D28B0DB

P577

Q47590210-BD897300-5F0E-4714-A23F-40A5082EAA2B

P698

Q47590210-2B349BC9-91DD-4A97-935F-23E535514D4E

P356

J.1445-5994.1999.TB00709.X

P1433

Australian and New Zealand journal of medicine

P1476

Advances in management of melanoma.

@en

P2093

P Hersey

http://www.w3.org/2001/XMLSchema#string

P2860

Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.

Two decades of the public health approach to skin cancer control in Australia: why, how and where are we now?

Impediments to successful immunotherapy.

Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994.

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group.

Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma.

Model predicting survival in stage I melanoma based on tumor progression.

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Gr

P304

292-299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1445-5994.1999.TB00709.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10868490

http://www.w3.org/2001/XMLSchema#string